HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target
Abstract Machines Histone deacetylases (HDACs) are involved in tumor progression, and some have been successfully targeted for cancer therapy.The expression of histone deacetylase 4 (HDAC4), a class IIa HDAC, was upregulated in our previous microarray screen.However, the role of HDAC4 dysregulation and mechanisms underlying tumor growth and metasta